Navigation Links
The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
Date:10/30/2008

>He noted that the record third quarter performance builds on record first and second quarters, adding, "We believe that these results graphically reconfirm the fundamental strength in our basic business model. As our outstanding facility leaders and their teams continue market-by-market to improve clinical quality, serve more skilled residents, adjust quickly to changes on the ground and lead previously-underperforming facilities to higher levels, Ensign continues to perform in spite of economic conditions."

Chief Financial Officer Alan Norman reported that revenue was also impacted by the recent California budget delay. "Because of the late budget California, which accounts for about half of our operational beds, has not yet finalized its 2009 Medi-Cal rate increase which should have gone into effect August 1, and so no increase was booked during the period in our California facilities." He noted that if the final rate resulted only in a 2.0% increase, the assumption used to develop management's previously-issued guidance, total revenue would have climbed to $116.7 million, additional an additional $0.01 in earnings per fully diluted share for the quarter. "We expect the rate to be finalized soon, and we will pick up any retroactive reimbursement increase in the 4th quarter," he added.

Christensen also discussed Ensign's industry-low debt ratio and the strength in its balance sheet. "We have been steadily building this balance sheet to prepare for both difficult economic cycles as well as compelling acquisition opportunities, and we believe that we are seeing the convergence of both of these events now and in the coming months," he said. "We believe we are well-positioned to perform and grow during the current economic downturn."

Year-to-date EBITDAR improved 20.5% to $52.4 million, compared to $43.5 million in the first nine months of 2007. Year-to-date EBITDA improved 32.9% to $41.2 million, compared to $31.0 million in the first nine months
'/>"/>

SOURCE The Ensign Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. The Ensign Group, Inc. Acquires Four Skilled Nursing Facilities
2. The Ensign Group Schedules 2008 Third Quarter Earnings Call for Friday, October 31, 2008
3. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
4. The Ensign Group Schedules 2008 Second Quarter Earnings Call for Thursday, August 7, 2008
5. The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th
6. The Ensign Group, Inc. Acquires Utah Skilled Nursing Facility
7. The Ensign Group, Inc. Reports First Quarter 2008 Earnings
8. The Ensign Group Schedules 2008 First Quarter Earnings Call for Thursday, May 8, 2008
9. The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings
10. The Ensign Groups Year-End Conference Call Scheduled for Friday, March 7, 2008
11. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... The dearth of qualified laboratory professionals (over 17% ... the next five years) and rising aging population ... application of advanced technology in testing laboratories has ... efficiency with minimal errors. This has led to ... combinatorial chemistry, automated clinical and analytical testing, diagnostics ...
(Date:4/1/2015)... The term “420” is thought to have originated ... of California teenagers would regularly get together after school to ... become a short-hand term for cannabis use – and April ... holiday for the marijuana culture. , To help celebrate this ... that help bring cannabis businesses and consumers together, has a ...
(Date:4/1/2015)... 01, 2015 Amada Senior Care , ... counseling, recently opened a new office in Rocky Mount, NC ... and Lee Bissett decided to make the move to senior ... after over 20 years of experience in management and consulting. ... , When asked what makes Amada different from ...
(Date:4/1/2015)... Decora Preset 30 Minute Countdown Timer, a product by renowned ... product helps in automatically switching off any electronic device. A ... device is automatically turned off after the set duration. , ... glad that this amazing product is now available on ‘The ... just a few clicks. The product has been designed by ...
(Date:4/1/2015)... When you’re suffering from back pain, the causes ... Identifying the causes of lingering back or neck pain is ... of chronic back pain is due to facet joint syndrome, ... back pain and offers many possible treatments, according to ... Atlantic Spine Center . , Dr. Liu clarifies the term ...
Breaking Medicine News(10 mins):Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 2Health News:Laboratory Accessories Market Worth $504.7 Million by 2020 – New Research Report by MarketsandMarkets 3Health News:The WeedLife Network Marks the Marijuana Culture’s 420 Celebrations by Offering Steep Advertising Discounts 2Health News:The WeedLife Network Marks the Marijuana Culture’s 420 Celebrations by Offering Steep Advertising Discounts 3Health News:Amada Senior Care Expands to Eastern North Carolina 2Health News:Leviton Decora Preset 30 Minute Countdown Timer Available On TheHardwareCity.com 2Health News:Demystifying Facet Joint Syndrome 2Health News:Demystifying Facet Joint Syndrome 3Health News:Demystifying Facet Joint Syndrome 4
... ELMWOOD PARK, N.J., July 2 PhytoCeuticals, Inc., ... care,formulations, who is the Fast to invent Stable ... granting IS Clinical from,Innovative Skin Care the right ... Inc. effective July 1, 2008., The IS ...
... and Eliza Hall Institute (WEHI) has contributed significantly ... biotechnology company, Bionomics, (ASX:BNO) and Germany-based pharmaceutical company, ... Licensing Agreement, Merck Serono will seek to develop ... autoimmune conditions. These prospective treatments will be based ...
... July 2 SuperGen, Inc.,(Nasdaq: SUPG ), ... and commercialization of therapies for solid tumors and,hematological ... and Chief Executive Officer, is scheduled to present ... 9, 2008 at the,Mandarin Oriental Hotel in New ...
... 2 The Female Health Company,(Amex: FHC ) ... Russell,Microcap(R) Index after the Russell Investment Group reconstituted its,comprehensive ... 27, 2008., The Russell Microcap(R) Index measures the ... the U.S. equity market. The Russell,Microcap(R) Index includes the ...
... Calif. and YOKOHAMA CITY, Japan, July 2 ... technology company,and Tokyo Electron Device Limited (TED), ... of inrevium evaluation board solutions, and,provider of ... the,distribution of Samplify,s patented Prism(TM) signal compression ...
... improved version of AmWay's MagnaBloc. , ... Memphis, TN ... pain management, is now available in a new, stronger form: ... released in the United States, and will be available worldwide within ...
Cached Medicine News:Health News:Termination of IS Clinical From Distributing PhytoCeuticals Formulas 2Health News:MS drug development agreement based on WEHI's medicinal chemistry 2Health News:SuperGen to Present at the Collins Stewart Growth Conference on July 9, 2008 2Health News:The Female Health Company Added to Russell Microcap(R) Index 2Health News:The Female Health Company Added to Russell Microcap(R) Index 3Health News:The Female Health Company Added to Russell Microcap(R) Index 4Health News:Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology 2Health News:New MagnaBloc™ Product Available from Gradient Medical 2
(Date:3/31/2015)... DIEGO , March 31, 2015 Neurocrine ... it has entered into an exclusive collaboration and licensing ... inhibitor, NBI-98854, in Japan and ... (TSE: 4508). Mitsubishi Tanabe intends to initially develop NBI-98854 ... associated with Huntington,s disease and tardive dyskinesia. Neurocrine retains ...
(Date:3/31/2015)... , March 31, 2015 UHC has ... the use of medical devices based on cost and ... physician preference items (PPIs). The study examined utilization of ... hospital,s supply expenses 1 —at 10 academic medical centers, ... stents, and cardiac valves. The study, ...
(Date:3/31/2015)... and ORANGEBURG, N.Y., March 31, 2015 /PRNewswire/ ...  VSCI) today announced the completion of their merger. ... and completion of the all-stock combination creates a ... Beginning on April 1, 2015, Cogentix Medical, Inc. ... CGNT. Cogentix Medical will have its U.S. headquarters ...
Breaking Medicine Technology:Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 2Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 4UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4
... Data,presented at the 2007 Annual Scientific Meeting of ... alli(R) (orlistat 60mg), the,only FDA- approved, over-the-counter (OTC) ... in helping them lose weight, and,not to potential ... data show that the weight loss achieved with ...
... Sanofi-aventis announced today,that the Japanese Ministry of ... for a Supplemental New Drug Application (sNDA) ... angina pectoris, non-ST elevation,myocardial infarction) for which ... Plavix(R) (clopidogrel). Approximately 100,000 patients develop ...
Cached Medicine Technology:Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects 2Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects 3Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 2Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 3Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 4Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned 5
... Projector Chart w/ Remote/Controller. Includes ... Adults & Children. Multiple 20/20 slides. ... Programmable feature allows you to customize your ... Halogen Illumination with Long Life. Variety of ...
... The Ultimate in ... Octopus 4.3 stabilizer features ... unmatched stability in the ... 4.3 Stabilizer features the ...
... Inc., the leader in beating heart bypass, ... new Starfish NS device is the first ... patient acceptance of surgical revascularization.,The Starfish NS ... the Multi-Vessel Small Thoracotomy (MVST) procedure without ...
Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device....
Medicine Products: